Variant report
Variant | nsv598173 |
---|---|
Chromosome Location | chr5:52495682-52499899 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:186)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr5:52496378-52496405 | K562 | blood: | n/a | n/a |
2 | BHLHE40 | chr5:52497763-52497949 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr5:52495710-52495995 | A549 | lung: | n/a | chr5:52495858-52495869 |
4 | CEBPB | chr5:52495712-52496013 | IMR90 | lung: | n/a | chr5:52495858-52495869 |
5 | CEBPB | chr5:52495715-52496023 | HepG2 | liver: | n/a | chr5:52495858-52495869 |
6 | CEBPB | chr5:52495713-52496009 | K562 | blood: | n/a | chr5:52495858-52495869 |
7 | CEBPB | chr5:52495844-52495875 | H1-hESC | embryonic stem cell: | n/a | chr5:52495858-52495869 |
8 | CEBPB | chr5:52495675-52496056 | Hela-S3 | cervix: | n/a | chr5:52495858-52495869 |
9 | CTCF | chr5:52497680-52497830 | SK-N-SH_RA | brain: | n/a | n/a |
10 | CTCF | chr5:52497660-52497810 | AG09319 | gingival: | n/a | n/a |
11 | CTCF | chr5:52497622-52497863 | HepG2 | liver: | n/a | n/a |
12 | CTCF | chr5:52497614-52497872 | A549 | lung: | n/a | n/a |
13 | CTCF | chr5:52497617-52497909 | K562 | blood: | n/a | n/a |
14 | CTCF | chr5:52497680-52497830 | GM12873 | blood: | n/a | n/a |
15 | CTCF | chr5:52497660-52497810 | HPF | lung: | n/a | n/a |
16 | CTCF | chr5:52497640-52497790 | HCFaa | heart: | n/a | n/a |
17 | CTCF | chr5:52497680-52497830 | BE2_C | brain: | n/a | n/a |
18 | CTCF | chr5:52497733-52497846 | Pancreas_OC | pancreas: | n/a | n/a |
19 | CTCF | chr5:52497691-52497825 | MCF-7 | breast: | n/a | n/a |
20 | CTCF | chr5:52497700-52497850 | GM12870 | blood: | n/a | n/a |
21 | CTCF | chr5:52497700-52497850 | K562 | blood: | n/a | n/a |
22 | CTCF | chr5:52497660-52497810 | WERI-Rb-1 | eye: | n/a | n/a |
23 | CTCF | chr5:52497680-52497830 | GM12875 | blood: | n/a | n/a |
24 | CTCF | chr5:52497640-52497790 | GM12801 | blood: | n/a | n/a |
25 | CTCF | chr5:52497681-52497844 | MCF-7 | breast: | n/a | n/a |
26 | CTCF | chr5:52497700-52497850 | GM12873 | blood: | n/a | n/a |
27 | CTCF | chr5:52497600-52497750 | AG04450 | lung: | n/a | n/a |
28 | CTCF | chr5:52497658-52497842 | NHEK | skin: | n/a | n/a |
29 | CTCF | chr5:52497780-52497930 | NB4 | blood: | n/a | n/a |
30 | CTCF | chr5:52497677-52497827 | ProgFib | skin: | n/a | n/a |
31 | CTCF | chr5:52497699-52497846 | GM13977 | blood: | n/a | n/a |
32 | CTCF | chr5:52497712-52497816 | A549 | lung: | n/a | n/a |
33 | CTCF | chr5:52497660-52497810 | HUVEC | blood vessel: | n/a | n/a |
34 | CTCF | chr5:52497722-52497772 | GM10248 | blood: | n/a | n/a |
35 | CTCF | chr5:52497700-52497850 | HRE | kidney: | n/a | n/a |
36 | CTCF | chr5:52497700-52497850 | GM12871 | blood: | n/a | n/a |
37 | CTCF | chr5:52497676-52497861 | HepG2 | liver: | n/a | n/a |
38 | CTCF | chr5:52497680-52497830 | HBMEC | blood vessel: | n/a | n/a |
39 | CTCF | chr5:52497567-52497964 | K562 | blood: | n/a | n/a |
40 | CTCF | chr5:52497600-52497750 | GM12875 | blood: | n/a | n/a |
41 | CTCF | chr5:52497677-52497833 | MCF-7 | breast: | n/a | n/a |
42 | CTCF | chr5:52497680-52497830 | HPAF | blood vessel: | n/a | n/a |
43 | CTCF | chr5:52497620-52497770 | GM12871 | blood: | n/a | n/a |
44 | CTCF | chr5:52497640-52497790 | MCF-7 | breast: | n/a | n/a |
45 | CTCF | chr5:52497565-52498052 | K562 | blood: | n/a | n/a |
46 | CTCF | chr5:52497640-52497790 | GM12878 | blood: | n/a | n/a |
47 | CTCF | chr5:52497740-52497890 | HUVEC | blood vessel: | n/a | n/a |
48 | CTCF | chr5:52497695-52497820 | MCF-7 | breast: | n/a | n/a |
49 | CTCF | chr5:52497657-52497847 | Gliobla | brain: | n/a | n/a |
50 | CTCF | chr5:52497660-52497810 | HFF-Myc | foreskin: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:52419531..52420160-chr5:52497344..52497892,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000213940 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs254481 | chr5:52495682-52495683 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs560227422 | chr5:52495683-52495684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369791907 | chr5:52495714-52495715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565971451 | chr5:52495744-52495745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs145282718 | chr5:52495793-52495794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10471843 | chr5:52495801-52495802 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs574764505 | chr5:52495830-52495831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567341357 | chr5:52495838-52495839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539640153 | chr5:52495926-52495927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531584303 | chr5:52495949-52495950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549892835 | chr5:52495982-52495983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571406359 | chr5:52495983-52495984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538905066 | chr5:52496044-52496045 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552077935 | chr5:52496067-52496068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554354441 | chr5:52496078-52496079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566095836 | chr5:52496118-52496119 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192323919 | chr5:52496146-52496147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184714946 | chr5:52496201-52496202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142481859 | chr5:52496223-52496224 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528033057 | chr5:52496226-52496227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573713538 | chr5:52496236-52496237 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189500290 | chr5:52496257-52496258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145092444 | chr5:52496273-52496274 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570236799 | chr5:52496291-52496292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577656020 | chr5:52496320-52496321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534694147 | chr5:52496324-52496325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs117486285 | chr5:52496328-52496329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs180832049 | chr5:52496338-52496339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184623793 | chr5:52496352-52496353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs189493917 | chr5:52496389-52496390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537469511 | chr5:52496398-52496399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368951629 | chr5:52496409-52496410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113551206 | chr5:52496414-52496415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531644629 | chr5:52496421-52496422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs117829992 | chr5:52496427-52496428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs62357407 | chr5:52496452-52496453 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs372818180 | chr5:52496467-52496468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532642465 | chr5:52496481-52496482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553146794 | chr5:52496488-52496489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566279193 | chr5:52496495-52496496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375826585 | chr5:52496496-52496497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536428532 | chr5:52496528-52496529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs112794882 | chr5:52496591-52496592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574191319 | chr5:52496634-52496635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373587991 | chr5:52496652-52496653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556202507 | chr5:52496658-52496659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs577517979 | chr5:52496668-52496669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138897687 | chr5:52496677-52496678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553549630 | chr5:52496684-52496685 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572235820 | chr5:52496686-52496687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:52489000-52507000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr5:52489600-52507800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr5:52491000-52496000 | Weak transcription | Hela-S3 | cervix |
4 | chr5:52495200-52496000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr5:52496000-52496400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr5:52496000-52496400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr5:52496000-52496400 | Enhancers | Fetal Lung | lung |
8 | chr5:52496000-52496400 | Enhancers | Dnd41 | blood |
9 | chr5:52496000-52496600 | Enhancers | Adipose Nuclei | Adipose |
10 | chr5:52496000-52496800 | Enhancers | Hela-S3 | cervix |